LD-2 disclosure · 1st Quarter - Report
PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA
Client
- Location
- District of Columbia · United States of America
Registrant
- Location
- Washington, District of Columbia, United States of America
Lobbying activities
5 issuesBudget/Appropriations
H.R. 2617: Consolidated Appropriations Act, 2023 (P.L. 117-328) H.R. 5376: Inflation Reduction Act of 2022 (P.L. 117-169) H.R. 6833: Continuing Appropriations and Ukraine Supplemental Appropriations Act, 2023 (P.L. 117-180) S. 4543: James M. Inhofe National Defense Authorization Act for Fiscal Year 2023 H.R. ____: Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2024 H.R. ____: Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2024 H.R.___: National Defense Authorization Act for Fiscal Year 2024 S._____: National Defense Authorization Act for Fiscal Year 2024 S._____: Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2024 S. ____: Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2024 FY 2024 Presidents Budget Request
LobbyistsLORI REILLY · DAVID KORN · RANDY BURKHOLDER · mr MICHAEL PAUL WOODY · ANNE PRITCHETT · ms JENNIFER MIRANDA BRYANT · COLLEEN MALONEY · KELLY GOLDBERG · RYAN KAAT · BART FORSYTH · NATALIE BURKHALTER · ANNE ELIZABETH ESPOSITO · PAUL GAGE · JAIMON M JACKSON · JOHN NAPPI · SCOTT WOODS · mr NICHOLAS LISOWSKI · mr TOM O'BRIEN · JOCELYN ULRICH · CORBIN SANTO
Covered position (CORBIN SANTO): Legislative Intern - Sen. Evan Bayh
TargetedSENATE · HOUSE OF REPRESENTATIVES
Copyright/Patent/Trademark
S. 79: Interagency Patent Coordination and Improvement Act of 2023 - Provisions related to Interagency Task Force S. 142: Preserve Access to Affordable Generics and Biosimilars Act - Provisions related to patent settlements S. 150: Affordable Prescriptions for Patients Act of 2023 - Provisions related to intellectual property and patents S. 574: Increasing Prescription Drug Competition Act - Patent-related policy issues Biopharmaceutical innovation and patent policy issues Bayh-Dole march-in rights policy issues Patent thicket policy issues Patent use codes policy issues
